¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"essential myoclonus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® myoclonus ÇÑ±Û °£´ë¼º±Ù°æ·Ã(Áõ)
¼³¸í   
  ±ÙÀ°ÀÇ ÀϺÎ, ±ÙÀ° Àüü, ¶Ç´Â ÀϱºÀÇ ±ÙÀ°ÀÇ °©ÀÛ½º·¯¿î ¼öÃàÀ¸·Î¼­ ½ÅüÀÇ ÀϺοµ¿ª¿¡ Á¦Çѵǰųª, È¤Àº ¿©·¯ ºÎÀ§¿¡¼­ µ¿½Ã¼º ¶Ç´Â ºñµ¿½Ã¼ºÀ¸·Î ³ªÅ¸³­´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myoclonus
    ±Ù(À°)°£´ë°æ·Ã
  • myoclonus multiplex
    ´Ù¹ß±Ù(À°)°£´ë°æ·Ã
  • essential
    1. º»ÅÂ- 2. Ư¹ß- 3. Çʼö-, Áø¼º-
  • essential amino acid
    Çʼö¾Æ¹Ì³ë»ê
  • essential anemia
    º»ÅºóÇ÷
  • essential bradycardia
    º»Å´À¸°¸Æ, º»Å¼­¸Æ
  • essential chorea
    º»Å¹«µµº´
  • essential dysmenorrhea
    º»Å¿ù°æÅë
  • essential element
    Çʼö¿ø¼Ò
  • essential fatty acid
    ÇʼöÁö¹æ»ê
  • essential fever
    º»Å¿­
  • essential hematuria
    º»ÅÂÇ÷´¢, ¿øÀκҸíÇ÷´¢
  • essential hypertension
    º»Å°íÇ÷¾Ð
  • essential hypotension
    º»ÅÂÀúÇ÷¾Ð
  • essential melanotic mucosal hyperplasia
    º»Å¸á¶ó´ÑÁ¡¸·Áõ½Ä
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myoclonus
    °£´ë¼º±Ù°æ·ÃÁõ
  • essential tremor
    º»Å¶³¸², À¯Àü¶³¸², ¿øÀθ𸦶³¸²
  • essential vertigo
    ¿øÀκҸí¾îÁö·³, º»ÅÂÇö±âÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myoclonus
    °£´ë¼º±Ù°æ·ÃÁõ
  • myoclonus multiplex
    ´Ù¹ß±Ù´ë¼º´ë¹ßÀÛ
  • massive myoclonus
    °£±Ù´ë¼º´ë¹ßÀÛ
  • essential anemia
    º»ÅºóÇ÷
  • essential amino acid
    Çʼö¾Æ¹Ì³ë»ê
  • essential fatty acid
    ÇʼöÁö¹æ»ê
  • essential bradycardia
    º»Å´À¸°¸Æ
  • essential chorea
    º»Å¹«µµº´
  • essential convulsion
    º»Å°æ·Ã
  • essential dysmenorrhea
    (¢¡primary dysmenorrhea) ¿ø¹ß¿ù°æÅë
  • essential progressive deafness
    Ư¹ßÁøÇ೭û
  • essential
    º»ÅÂ-, Ư¹ß-, Çʼö-, Áø¼º-
  • essential element
    Çʼö¿ø¼Ò
  • essential fever
    º»Å¿­
  • essential hematuria
    ¿øÀκҸíÇ÷´¢, ¼ø¼öÇ÷´¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • generalized essential telangiectasia
    Àü½Å¼º º»Å¼º ¸ð¼¼Ç÷°ü È®Àå(Áõ)
  • hypertension,essential
    º»Å¼º(Üâ÷¾àõ)
  • Lafora body type of myoclonus
    ¶óÆ÷¶ó üÇü ¸¶ÀÌ¿ÀŬ·Î´©½º.
  • generalized myoclonus
    Àü½Å¼º ¹Ì¿ÀŬ·Î´©½º, Àü½Å¼º °£´ë
  • generalized myoclonus See convulsion
    Àü½Å¼º °£´ë¼º±Ù°æ·Ã(îïãóàõÊàÓÛàõÐÉÌâÕý)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • generalized myoclonus
    Àü½Å¼º ¹Ì¿ÀŬ·Î´©½º, Àü½Å¼º °£´ë
  • generalized myoclonus See convulsion
    Àü½Å¼º °£´ë¼º±Ù°æ·Ã(îïãóàõÊàÓÛàõÐÉÌâÕý)
  • massive myoclonus
    ¹Ì¿ÀŬ·Î´©½º´ë¹ßÀÛ(¡­ÓÞÛ¡íÂ).
  • myoclonus
  • myoclonus epilepsy
    ¹Ì¿ÀŬ·Î´©½º°£Áú(¡­ÊÖòð).
  • myoclonus multiplex
    ´Ù¹ß¼º ±¸°£´ë°æ·Ã(Áõ) (ÒýÛ¡àõÏ¢ÊàÓÛÌâÕýñø), ´Ù¹ß¼º °£´ë¼º ±Ù°æ·Ã(Áõ).
  • nocturnal myoclonus
    ¾ß°£¼º(¹Ì¿ÀŬ·Î´©½º)±Ù°æ·Ã.
  • ocular myoclonus
  • palatal myoclonus
    ±¸°³±Ù°æ·Ã
  • palatal myoclonus
    ±¸°³±Ù°æ·Ã(¡­ÐÉÌâÕý).
  • visual myoclonus
    ½Ã°¢¼º ±Ù°æ·Ã.
  • visual myoclonus
    ½Ã°¢¼º ±Ù°æ·Ã
  • essential
    º»Å¼ºÀÇ, Ư¹ß¼ºÀÇ, ÇʼöÀÇ, Áø
  • essential albuminuria
    º»Å¼º ´Ü¹é´¢.
  • essential amino acid
    Çʼö¾Æ¹Ì³ë»ê
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • essential amino acid
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«)
  • essential amino acid index
    Çʼö(ù±âÎ) ¾Æ¹Ì³ë»ê(ß«) Áö¼ö(ò¦â¦)
  • essential enzyme
    Çʼö È¿¼Ò (ù±âÎý£áÈ)
  • essential fatty acid
    Çʼö Áö¹æ»ê (ù±âÎò·Û¸ß«)
  • essential gene
    Çʼö À¯ÀüÀÚ (ù±âÎë¶îîí­)
  • essential metabolite
    Çʼö ´ë»ç¹° (ù±âÎÓÛÞóÚª)
  • essential nutrient
    Çʼö ¿µ¾ç¼Ò (ù±âÎç½å×áÈ)
  • essential oil
    ÇʼöÀ¯(ù±âÎêú)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • essential hypertension
    º»Å¼º°íÇ÷¾Ð
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ET educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e...
CRSM cherry red spot myoclonus
DME degenerative myoclonus epilepsy; dimethyl diester; dimethyl ether; diphasic meningoencephalitis; dir...
JME juvenile myoclonus epilepsy
MERRF myoclonus epilepsy with ragged red fibers [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MERRF Myoclonus epilepsy associated with ragged-red fibers
MERRF Myoclonus epilepsy with ragged-red fibers
PME Progressive Myoclonus Epilepsy
MERRF myoclonus epilepsy and ragged red fiber
EMEM Eagle's Minimal Essential Medium
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myoclonus
    °£´ë¼º ±Ù°æ·Ã
    1. ¸Å¿ì ª°í ºÒ¼öÀÇÀûÀÌ¸ç ºÒ±ÔÄ¢ÇÑ ±Ù¼öÃàÀÌ´Ù. ÈÞÁö±â¿¡ ÀÚ¹ßÀûÀ¸·Î ÀÚ±Ø °¨°¢¿¡ ¹ÝÀÀÇÏ¿© ¶Ç´Â ¼öÀÇÀû ¿îµ¿À¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. 2. Çϳª³ª ±× ÀÌ»óÀÇ ±ÙÀ°±ºÀÇ ¼öÃàÀ¸·Î ÀÎÇÑ °£´ë¼ºÀÇ °æ·ÃÀ̳ª ¿¬Ãà.
  • myoclonus multiplex
    ´Ù¹ß¼º ±¸°£´ë °æ·Ã, ´Ù¹ß¼º ±¸°£´ë °æ·ÃÁõ
  • Eagle`s minimal essential medium
    ÀÌ±Û ¹èÁö
    ¼¼Æ÷ ¹è¾ç¾×ÀÇ ÀÏÁ¾. 3Á¾·ùÀÇ ¾Æ¹Ì³ë»ê°ú 8Á¾·ùÀÇ ºñŸ¹ÎÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¸ç º¸Åë Ç÷û 5% ÀÌÇÏ¿¡¼­ À¯Áö ¹èÁö·Î¼­ »ç¿ëµÇ°í 10-20%ÀÇ Ç÷û ÷°¡·Î ¸¹Àº ¼¼Æ÷´Â ±ØÈ÷ ¾çÈ£ÇÑ ¹ßÀ°À» ³ªÅ¸³½´Ù.
  • essential amino acid
    Çʼö ¾Æ¹Ì³ë»ê
    ´Ü¹éÁúÀÇ ±âº» ±¸¼º ´ÜÀ§. ´Ü¹éÁúÀº ü³»¿¡¼­ ¾Æ¹Ì³ë»êÀ¸·Î ºÐÇØµÇ°í ³ª¼­ Èí¼ö, ÀÌ¿ëµÈ´Ù. µû¶ó¼­ ´Ü¹éÁúÀÇ ¿µ¾ç°¡´Â ±× ¼Ó¿¡ ÇÔÀ¯µÇ´Â ¾Æ¹Ì³ë»êÀÇ Á¾·ù¿Í ¾ç¿¡ ÀÇÇÏ¿© Á¤ÇØÁø´Ù. ¾Æ¹Ì³ë»êÀº µ¿¹°ÀÇ Ã¼³»¿¡¼­ ´Ù¸¥ ¾Æ¹Ì³ë»êÀ¸·ÎºÎÅÍ ¸¸µé¾îÁö´Â °Í°ú, ü³»¿¡¼­´Â ÇÕ¼ºµÇÁö ¾Ê°í À½½ÄÀ¸·Î ¼·ÃëµÇ¾î¾ß ÇÏ´Â °ÍÀÌ ÀÖ´Ù. µû¶ó¼­ ¼·ÃëÇÏÁö ¾ÊÀ¸¸é ¿ÏÀüÇÑ ´Ü¹éÁúÀÌ µÇÁö ¾Ê´Â´Ù. ÀÌ·¸°Ô ü³»¿¡¼­ ÇÕ¼ºÇÒ ¼ö ¾ø´Â ¾Æ¹Ì³ë»êÀ» Çʼö ¾Æ¹Ì³ë»ê ¶Ç´Â ºÒ°¡°á ¾Æ¹Ì³ë»êÀ̶ó°í ÇÑ´Ù. Çʼö ¾Æ¹Ì³ë»êÀÇ Á¾·ù´Â µ¿¹°ÀÇ Á¾·ù³ª ¼ºÀå ½Ã±â¿¡ µû¶ó ´Ù¸£Áö¸¸, ¼ºÀÎÀÇ °æ¿ì¿¡´Â ´ÙÀ½ÀÇ 8Á¾ÀÌ´Ù. À̼ҷù½Å, ·ù½Å, ¸®½Å, Æä´Ò¾Ë¶ó´Ñ, ¸ÞƼ¿À´Ñ, Æ®·¹¿À´Ñ, Æ®¸³ÅäÆÇ, ¹ß¸°ÀÌ´Ù. ¾î¸°¾ÆÀÌÀÇ °æ¿ì¿¡´Â ¿©±â¿¡ È÷½ºÆ¼µòÀÌ ´õÇØÁø´Ù.
  • essential fatty acid
    Çʼö Áö¹æ»ê
    °íµîµ¿¹°ÀÇ ¼ºÀå ¶Ç´Â °Ç°­ »óÅÂÀÇ À¯Áö¸¦ À§ÇÏ¿© ü¿Ü·ÎºÎÅÍ ¼·ÃëÇØ¾ß ÇÒ Áö¹æ»ê. ºñŸ¹Î F¶ó°íµµ ÇÑ´Ù. Áö¹æÀº ü³»¿¡¼­ ÁÖ·Î ¿¡³ÊÁö¿øÀÌ µÇ¹Ç·Î ´Ù¸¥ °ÍÀ¸·ÎºÎÅÍ Ä®·Î¸®¸¦ ÃëÇϸé Áö¹æÀº ÇÊ¿ä¾øÁö ¾ÊÀº°¡ ÇÏ´Â Àǹ®ÀÌ »ý±ä´Ù. ±×·¯³ª À½½Ä ¼Ó¿¡ Áö¹æÀÌ ÀüÇô ¾øÀ¸¸é µ¿¹°ÀÇ ¼ºÀåÀÌ Á¤ÁöÇÏ°í Æ¯À¯ÇÑ ÇǺο°ÀÌ »ý±ä´Ù. ÀÌ Áõ¼¼´Â ¸®³î»ê, ¸®³î·»»ê, ¾Æ¶ó۵·»ê Áß ¾î´À °ÍÀ» ÇÔÀ¯ÇÏ´Â Áö¹æÀ» Åõ¿©Çϸé Ä¡À¯µÈ´Ù. ±×·¡¼­ À̵é Áö¹æÀ» ¾Æ¹Ì³ë»êÀÇ ¿¹¿¡ µû¶ó Çʼö Áö¹æ»êÀ̶ó°í ÇÑ´Ù. ÀÌ»óÀÇ ¼¼ °¡Áö Áö¹æ»ê Áß¿¡¼­ ¸®³î»êÀº ÀϹÝÀûÀÎ À¯Áö¿¡ ³Î¸® ÇÔÀ¯µÇ¾î ÀÖÀ¸¹Ç·Î, º¸ÅëÀÇ Áö¹æÀ» ¼·ÃëÇϸé Áö¹æ»êÀÌ °áÇÌÇÏ´Â ÀÏÀº ¾ø´Ù.
  • essential hypertension
    º»Å¼º °íÇ÷¾Ð
    1. Ưº°ÇÑ ¿øÀÎÀÌ ¾Ë·ÁÁöÁö ¾ÊÀº °íÇ÷¾ÐÀ» ÀǹÌÇϸç ÀÌ´Â Àüü °íÇ÷¾Ð ȯÀÚÀÇ 85-90£¥¸¦ Â÷ÁöÇÑ´Ù. 2. À¯Àü, Á¤½ÅÀû ½ºÆ®·¹½º, ¿°ºÐÀÇ Áõ°¡ µî Ç÷¾Ð »ó½ÂÀÌ º¹ÇÕÀûÀÎ ¿øÀÎ ÇüÅ·Π³ªÅ¸³­´Ù.
  • essential mixed cryoglobulinemia
    ¿ø¹ß¼º È¥ÇÕ ÇѳÃ-±Û·Îºí¸°Áõ
    µå¹® Àü½Å¼º ÁúȯÀ¸·Î¼­ IgG-IgM º¹ÇÕü°¡ ÁÖ ¼ººÐÀÎ ÇѳÃ-±Û·Îºí¸°ÀÇ Ä§ÂøÀ¸·Î ÇǺΠÇ÷°ü¿°, Ȱ¸·¿° ¹× ÃÊÁ¡¼º ³»Áö ¹Ì¸¸¼º Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°ÀÌ ³ªÅ¸³­´Ù. CÇü °£¿°°ú °°Àº °¨¿°¿¡ ¼Ó¹ßÇÏ´Â ÇѳÃ-±Û·Îºí¸°Ç÷Áõ¿¡¼­´Â ¸·Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°ÀÌ °üÂûµÇ±âµµ ÇÑ´Ù.
  • essential oil
    Á¤À¯
  • essential tremor
    Ư¹ß¼º ÁøÀü
    ¾ç¼ºÀÇ À¯ÀüÀû °¡Á·Àû Ãßü ¼¼Æ÷¿Ü ÁøÀü
  • minimum essential medium
    ÃÖ¼Ò Çʼö ¹èÁö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Baltic myoclonus disease One of the familial light sensitive myoclonic epilepsies. Unlike Lafora body polymyoclonus, where inclusion bodies are seen in the brain cells, the prognosis is often favourable. Probably an autosomal recessive disorder.
(05 Mar 2000)
palatal myoclonus Rhythmic contractions of the soft palate, the facial muscles, and the diaphragm, related to lesions of the olivocerebellar pathways.
See: palatal nystagmus.
(05 Mar 2000)
cherry-red spot myoclonus syndrome <syndrome> A neuronal storage disorder in children characterised by a cherry red spot at the macula, progressive myoclonus, and easily controlled seizures; the result of sialidase deficiency. Type 1 is characterised by normal body habitus, cherry red macula, myoclonus, and normal beta-galactosidase levels; type 2 by short stature, bony abnormalities, and deficient beta-galactosidase.
Synonym: sialidosis.
(05 Mar 2000)
myoclonus Twitching or spasm of a muscle or a group of muscles.
(27 Sep 1997)
myoclonus epilepsy A clinically diverse group of epilepsy syndromes, some benign, some progressive. Many are hereditary with mendelian and nonmendelian mitochondrial inheritance. All are characterised by the occurrence of myoclonus, which may be limited or predominate in the condition. Specific syndromes include cherry red spot myoclonus syndrome, ceroid lipofuscinosis, myoclonic epilepsy with ragged red fibres, and Baltic myoclonus.
Synonym: localization related epilepsy.
(05 Mar 2000)
myoclonus multiplex An ill-defined disorder marked by rapid and widespread muscle contractions.
Synonym: paramyoclonus multiplex, polyclonia, polymyoclonus.
(05 Mar 2000)
stimulus sensitive myoclonus Myoclonus induced by a variety of stimuli, e.g., talking, calculation, loud noises, tapping, etc.
(05 Mar 2000)
nocturnal myoclonus Frequently repeated muscular jerks occurring at the moment of dropping off to sleep.
(05 Mar 2000)
benign essential tremor A benign tremor inherited as a dominant character; it may be a rapid oscillation resembling that seen in thyrotoxicosis, a coarse tremor during rest and inhibited by a voluntary effort, or one which appears only upon movement.
Synonym: benign essential tremor, familial tremor.
(05 Mar 2000)
drugs, essential Drugs considered essential to meet the health needs of a population as well as to control drug costs. (world health organization action programme on essential drugs, 1994, p3)
(12 Dec 1998)
osteolysis, essential Syndromes of bone destruction where the cause is not obvious such as neoplasia, infection, or trauma. The destruction follows various patterns: massive (gorham disease), multicentric (hajdu-cheney syndrome, winchester syndrome), or carpal/tarsal.
(12 Dec 1998)
Eagle's minimum essential medium A tissue culture medium similar to Eagle's basal medium but with different amounts and a few exclusions (e.g., antibiotics and phenol red).
(05 Mar 2000)
essential 1. Belonging to the essence, or that which makes an object, or class of objects, what it is. "Majestic as the voice sometimes became, there was forever in it an essential character of plaintiveness." (Hawthorne)
2. Hence, really existing; existent. "Is it true, that thou art but a a name, And no essential thing?" (Webster (1623))
3. Important in the highest degree; indispensable to the attainment of an object; indispensably necessary. "Judgment's more essential to a general Than courage." (Denham) "How to live? that is the essential question for us." (H. Spencer)
4. Containing the essence or characteristic portion of a substance, as of a plant; highly rectified; pure; hence, unmixed; as, an essential oil. "Mine own essential horror."
5. Necessary; indispensable; said of those tones which constitute a chord, in distinction from ornamental or passing tones.
6. <medicine> Idiopathic; independent of other diseases.
<biology> Essential character, a class of volatile oils, extracted from plants, fruits, or flowers, having each its characteristic odour, and hot burning taste. They are used in essences, perfumery, etc, and include many varieties of compounds; as lemon oil is a terpene, oil of bitter almonds an aldehyde, oil of wintergreen an ethereal salt, etc.; called also volatile oils in distinction from the fixed or nonvolatile.
Origin: Cf. F. Essentiel. See Essence.
Source: Websters Dictionary
(01 Mar 1998)
essential albuminuria A collective term for types that are not the result of pathologic changes in the kidneys.
Synonym: essential albuminuria.
(05 Mar 2000)
essential amino acid <biochemistry> Those amino acids that cannot be synthesised by an organism and must therefore be present in the diet. The term is often applied anthropocentrically to those amino acids required by humans (Ileu, Leu, Lys, Met, Phe, Thr, Try, & Val), though rats need two more (Arg & His).
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • essential
    º»ÁúÀûÀÎ,ÇʼöÀÇ
  • non-essential
    ºñº»ÁúÀûÀÎ
  • essential
    º»ÁúÀûÀÎ;½ÇÁúÀÇ;ÇʼöÀÇ;Á¤¼öÀÇ;¿¡¼¾½ºÀÇ;±âº»ÀÇ;º»Áú;¿äÁ¡;¿ä¼Ò
  • essential amino acid
    (È­)Çʼö ¾Æ¹Ì³ë»ê
  • essential oil
    (½Ä¹°¼º)Á¤À¯;¹æÇâÀ¯(Çâ¼öÀÇ ¿ø·á)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á